Suchergebnisse - "WANG MING-HAI"

PubPharm (163)

1

Combination of Albumin/Fibrinogen Ratio and Admission Hunt-Hess Scale Score as an Independent Predictor of Clinical Outcome in Aneurysmal Subarachnoid Hemorrhage

enthalten in: World neurosurgery | 2024

von Wang, H. | Ma, J. | Guo, Y. | +9

2

Preparation and use of anti-MET-and-RON bispecific antibody and antibody-drug conjugate thereof

enthalten in: Europäisches Patentamt | 2023

von WANG MING-HAI | YAO HANG-PING

3

Preparation and use of anti-MET-and-RON bispecific antibody and antibody-drug conjugate thereof

enthalten in: Europäisches Patentamt | 2023

von WANG MING-HAI | YAO HANG-PING

4

RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells

enthalten in: Current cancer drug targets | 2023

von Suthe, S. | Yao, H. | Weng, T. | +1

5

miR-219a-5p inhibits the pyroptosis in knee osteoarthritis by inactivating the NLRP3 signaling via targeting FBXO3

enthalten in: Environmental toxicology | 2022

von Wang, Q. | Huang, P. | Wu, J. | +6

6

AIoT enabled resampling filter for temperature extraction of the Brillouin gain spectrum

enthalten in: Optics express | 2022

von Wang, M. | Sui, Y. | Zhou, W. | +2

7

Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase

enthalten in: Current cancer drug targets | 2022

von Hudson, R. | Yao, H. | Suthe, S. | +2

8

Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase

enthalten in: Current cancer drug targets | 2022

von Hudson, R. | Yao, H. | Suthe, S. | +2

9

miR‐219a‐5p inhibits the pyroptosis in knee osteoarthritis by inactivating the NLRP3 signaling via targeting FBXO3

enthalten in: Environmental Toxicology | 2022

von Wang, Q. | Huang, P. | Wu, J. | +6

10

Monoclonal antibodies specific to the plexin-semaphorin-integrin (PSI) domain of RON for drug delivery and its application in cancer therapy

enthalten in: Europäisches Patentamt | 2021

von WANG MING-HAI | YAO HANG-PING

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]